Rising prevalence of chronic diseases, such as cancer and diabetes, and growing adoption of advanced diagnostic techniques are predicted to fuel market growth
The global in vitro diagnostics quality control market size is expected to reach USD 1,306.5 million by 2028 at a CAGR of 4.1%, according to the latest report by Reports and Data. Rising prevalence of chronic and cardiovascular diseases (CVDs), growing burden of infectious diseases, and rising demand for advanced and rapid diagnostic systems are key factors expected to increase global market growth in the upcoming years. Rising demand for third-party IVD quality controls, increasing number of accredited clinical laboratories, technological advances in IVD techniques, and favorable regulatory policies for in vitro diagnostics quality control are expected to further drive market growth over the forecast years. In addition, rapidly increasing demand for at-home IVD products such as blood glucose monitoring kits and growing focus of manufacturers on providing efficient quality control support are other vital factors supporting the growth of this market.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1508
The report provides extensive coverage of the supply chain, key players of the industry, consumer base, company profiles, production and consumption rate, primary applications, and other relevant data. It provides an in-depth assessment of the key companies operating in the market along with their company profiles, business overview, production and manufacturing capacity, product portfolio, financial standing, global position, and business expansion plans. It also studies recent mergers and acquisitions, joint ventures, product launches, partnerships, collaborations, and agreements among other. The report also provides insights into new entrants and their strategic alliances to gain a robust footing in the market.
Key Manufacturers in the Global CIn Vitro Diagnostics Market:
Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Roche Diagnostics, Siemens Healthineers, Technopath Clinical Diagnostics, Fortress Diagnostics, Randox Laboratories Ltd., Bio-Techne Corporation, Ortho-Clinical Diagnostics, Inc., SeraCare Life Sciences Inc., Sysmex Corporation, and Helena Laboratories
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1508
The report also provides an extensive regional segmentation to offer the readers key insights into the spread of the market over key geographical regions. It covers production and consumption patterns, import/export, supply and demand, consumer demand and behavior, key trends, and presence of key players in each region. The report also offer a country-wise analysis to impart a better understanding of the revenue growth of the market in each region.
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, France, Rest of Europe)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
By Product Service Type (Revenue, USD Million; 2018-2028)
- Quality Control Products
- Whole Blood-based Controls
- Serum/Plasma-based Controls
- Urine-based Controls
- Data Management Solutions
- Quality Assurance Services
- Source-based IVD Quality Controls
By Manufacturer (Revenue, USD Million; 2018-2028)
- Third-Party Control Manufacturers
- Original Equipment Manufacturers (OEMs)
- Instrument-Specific Controls
- Independent Controls
By Application (Revenue, USD Million; 2018-2028)
- Immunochemistry/Immunoassay
- Coagulation Hemostasis
- Molecular Diagnostics
- Clinical Chemistry
- Microbiology
- Hematology
- Others
By End-user (Revenue, USD Million; 2018-2028)
- Hospitals
- Home Care
- Clinical Laboratories
- Academic Research Institutes
- Contract Research Organizations (CROs)
- IVD Manufacturers
- Others
To know more about the report @ https://www.reportsanddata.com/report-detail/in-vitro-diagnostics-ivd-quality-control-market
Key Questions Addressed in the Report:
- What is the market size the global CIn Vitro Diagnostics market is expected to reach over the forecast period? What is the expected CAGR?
- What are the key segments of the market?
- What are the key products and applications of the CIn Vitro Diagnostics market?
- What factors are expected to drive and restrain market growth over the forecast period?
- What are the key outcomes of SWOT analysis and Porter’s Five Forces analysis?
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1508
Thank you for reading our report. The report can be customized based on regional segmentation and competitive landscape. Kindly get in touch with us to know more and our team will ensure the report is well suited to meet your requirements.
Browse more related reports:
Electronic Clinical Outcome Assessment (eCOA) Solution Market: https://www.biospace.com/article/electronic-clinical-outcome-assessment-ecoa-solution-market-to-reach-usd-3-48-billion-by-2028/
Aminoglycosides Market: https://www.biospace.com/article/aminoglycosides-market-size-to-reach-usd-2-16-billion-by-2028-reports-and-data/
Insulin Pens Market: https://www.biospace.com/article/insulin-pens-market-size-to-reach-usd-46-43-billion-in-2028-reports-and-data/
Cancer Diagnostics Market: https://www.biospace.com/article/cancer-diagnostics-market-to-reach-usd-252-22-billion-by-2027-reports-and-data/
Emergency Ventilator Market: https://www.biospace.com/article/emergency-ventilator-market-size-to-reach-usd-1-616-13-million-in-2028-reports-and-data/
